FibroBiologics, Inc. Common Stock

General ticker "FBLG" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $16.9M (TTM average)

FibroBiologics, Inc. Common Stock does not follow the US Stock Market performance with the rate: -36.5%.

Estimated limits based on current volatility of 7.3%: low 1.11$, high 1.28$

Factors to consider:

  • Total employees count: 15 (+15.4%) as of 2025
  • Company does not operate outside US (retrieved using AI)
  • Top business risk factors: Going concern doubt, Operational and conduct risks, Need for additional capital, FDA approval delays, Volatile stock price
  • Current price 62.6% below estimated low
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [3.44$, 11.91$]
  • 2026-12-31 to 2027-12-31 estimated range: [3.39$, 11.04$]

Similar symbols

Short-term FBLG quotes

Long-term FBLG plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $8.89MM $13.74MM $16.65MM
Operating Income $-8.89MM $-13.74MM $-16.65MM
Non-Operating Income $-7.60MM $2.58MM $-2.00MM
Interest Expense $0.15MM $0.02MM $0.20MM
R&D Expense $2.37MM $4.50MM $7.41MM
Income(Loss) $-16.48MM $-11.16MM $-18.65MM
Net Income(Loss)* $-16.48MM $-11.16MM $-18.65MM
Stockholders Equity $1.25MM $2.73MM $6.16MM
Assets $11.82MM $16.45MM $9.62MM
Operating Cash Flow $-6.40MM $-11.90MM $-16.39MM
Capital expenditure $0.49MM $0.18MM $0.26MM
Investing Cash Flow $-0.49MM $-0.18MM $-0.26MM
Financing Cash Flow $13.79MM $16.91MM $7.57MM
Earnings Per Share** $-10.15 $-6.79 $-8.35

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.